Clinical Trials Browser

INDUSTRY × Interventional × Celecoxib × Clear all

NCT04041050 2025-02-14

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

Phase 1 Active not recruiting

MyeloidOther hematologic neoplasm

Myeloproliferative Disorders, Neoplasms, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT05438303 2023-01-12

Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers

Phase 1 Completed

Breast Neoplasms

NCT00585312 2021-02-21

CHIP

Phase 3 Terminated

106 enrolled 10 charts

Gastrointestinal

Adenomatous Polyposis Coli

NCT00038103 2010-02-25

Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen

Phase 2 Completed

111 enrolled 14 charts

Breast Neoplasms

NCT00036283 2008-09-29

Chemoprevention of Oral Premalignant Lesions

Phase 2 Completed

Precancerous Conditions

NCT00037180 2008-09-29

For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

Phase 2 Terminated

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms